Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of PT105 vs PT105R in Healthy Postmenopausal Women
NCT04783636Phase 1Unknown
- Sponsor
- Peptron Inc.
- Start
- Mar 2021
- Primary completion
- Jul 2021
- Modality
- Peptides, Small Molecules
01
Overview
Phase 1, randomised, open-label trial of leuprolide in prostate cancer (PCa) (2 arms), sponsored by Peptron Inc. Primary endpoints: Area Under the Curve from time 0 to time t, Area Under the Curve to the last measurable concentration and 2 more. Status: unknown.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04783636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04783636.